Wipfli Financial Advisors’s Myovant Sciences Ltd. MYOV Stock Holding History

Wipfli Financial Advisors’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$2K	Buy	+97	New	+$1.55K	﹤0.01%	2349

Other funds holding MYOV

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Wipfli Financial Advisors's MYOV Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Myovant Sciences Ltd. (MYOV) in Q3 2022: 97 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #2349 among its holdings.

98 funds tracked by Wall St. Rank hold MYOV as of Q3 2022.

Wipfli Financial Advisors held 97 shares of Myovant Sciences Ltd. worth $2K as of Q3 2022.
Myovant Sciences Ltd. was a new Wipfli Financial Advisors position in Q3 2022.
Myovant Sciences Ltd. made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2349 holding.
98 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.